Jump to content
RemedySpot.com

Fw: New discussion: PhV in medical research - XXIII

Rate this topic


Guest guest

Recommended Posts

Dear members,

The commonly used causality assessment scale - Naranjo's scale is objective method of assessment. The two most important questions it it are -

1) Did the AR reappear when drug was readministered (Rechallenge)?

2) Was the drug detected in the blood [or other fluids] in a concentration known to be toxic?

Rechallenge with drug is "Generally" not done (but if done it has to be with utmost precautions and starting with lower dose in cases of serious AEs)

Also, blood concentration of the drug is generally not meaured.

Because of these two important reasons, the Nanranjo's score comes to be Probable or possible.

Regards, Dr. Vijay M. katekhayePostgraduate StudentDept. of Pharmacology,LTMMC & LTMGH, Sion,Mumbai - 400 022 Ph - +919619313060

----- Forwarded Message ----From: Dr. vijay Katekhaye <dr.vijaykatekhaye@...>netrum Sent: Fri, 29 October, 2010 8:22:22 PMSubject: New discussion: PhV in medical research - XVI

Dear members,The most of the results for the Naranjo's Causality Assessment scale fall between the probable or possible category.What is most important factor responsible for such happening? or in other words, what is the most important factor in Naranjo's causality assessment scale?

Regards,Dr. Vijay M. katekhayePostgraduate StudentDept. of Pharmacology,LTMMC & LTMGH, Sion,Mumbai - 400 022 Ph - +919619313060

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...